Literature DB >> 15879096

Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine.

John Colgan1, Mohammed Asmal, Bin Yu, Jeremy Luban.   

Abstract

Cyclosporine is an immunosuppressive drug that is widely used to prevent organ transplant rejection. Known intracellular ligands for cyclosporine include the cyclophilins, a large family of phylogenetically conserved proteins that potentially regulate protein folding in cells. Immunosuppression by cyclosporine is thought to result from the formation of a drug-cyclophilin complex that binds to and inhibits calcineurin, a serine/threonine phosphatase that is activated by TCR engagement. Amino acids within the cyclophilins that are critical for binding to cyclosporine have been identified. Most of these residues are highly conserved within the 15 mammalian cyclophilins, suggesting that many are potential targets for the drug. We examined the effects of cyclosporine on immune cells and mice lacking Ppia, the gene encoding the prototypical cyclophilin protein cyclophilin A. TCR-induced proliferation and signal transduction by Ppia(-/-) CD4(+) T cells were resistant to cyclosporine, an effect that was attributable to diminished calcineurin inhibition. Immunosuppressive doses of cyclosporine failed to block the responses of Ppia(-/-) mice to allogeneic challenge. Rag2(-/-) mice reconstituted with Ppia(-/-) splenocytes were also cyclosporine resistant, indicating that this property is intrinsic to Ppia(-/-) immune cells. Thus, among multiple potential ligands, CypA is the primary mediator of immunosuppression by cyclosporine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879096     DOI: 10.4049/jimmunol.174.10.6030

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland.

Authors:  Sonja E Volker; Shannon E Hedrick; Yvonne B Feeney; Charles V Clevenger
Journal:  Cancer Res       Date:  2018-06-29       Impact factor: 12.701

2.  Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

Authors:  Kyoung-in Cho; Hemangi Patil; Eugene Senda; Jessica Wang; Haiqing Yi; Sunny Qiu; Dosuk Yoon; Minzhong Yu; Andrew Orry; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

3.  Targeting the cyclophilin domain of Ran-binding protein 2 (Ranbp2) with novel small molecules to control the proteostasis of STAT3, hnRNPA2B1 and M-opsin.

Authors:  Kyoung-In Cho; Andrew Orry; Se Eun Park; Paulo A Ferreira
Journal:  ACS Chem Neurosci       Date:  2015-06-12       Impact factor: 4.418

4.  Cyclophilin A Aggravates Collagen-Induced Arthritis via Promoting Classically Activated Macrophages.

Authors:  Zhai Dongsheng; Fu Zhiguang; Jia Junfeng; Lu Zifan; Wang Li
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

5.  Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion.

Authors:  Peter Seizer; Carmen Ochmann; Tanja Schönberger; Sebastian Zach; Melanie Rose; Oliver Borst; Karin Klingel; Reinhard Kandolf; H Robson MacDonald; Romana A Nowak; Stefan Engelhardt; Florian Lang; Meinrad Gawaz; Andreas E May
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-24       Impact factor: 8.311

Review 6.  Apoptosis-inducing factor: structure, function, and redox regulation.

Authors:  Irina F Sevrioukova
Journal:  Antioxid Redox Signal       Date:  2011-03-10       Impact factor: 8.401

Review 7.  From Drosophila to humans: reflections on the roles of the prolyl isomerases and chaperones, cyclophilins, in cell function and disease.

Authors:  Paulo A Ferreira; Andrew Orry
Journal:  J Neurogenet       Date:  2012-02-14       Impact factor: 1.250

8.  Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis.

Authors:  Weinong Han; Keyoumars Soltani; Mei Ming; Yu-Ying He
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-30

Review 9.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

10.  Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-κB.

Authors:  Shan Sun; Qiuwei Wang; An Giang; Cong Cheng; Chia Soo; Cun-Yu Wang; Linda M Liau; Robert Chiu
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.